CAR T-Cell Therapy--Hype or Hope?

CAR T-Cell Therapy: Separating the Hype from the Hope

Does immune cellular therapy with CAR T-cells offer a potentially curative approach for myeloma? That’s what this week’s flurry of news articles from the 2017 Annual Meeting of the American Society of Clinical Oncology (ASCO) seemed to suggest. But not so fast, cautions IMF Chairman Dr. Brian Durie in his blog this week: “It is way too soon, in my opinion, for such suggestions, both in terms of treatment benefit and toxicities and/or side effects.”  Read Dr. Durie’s blog.

ASCO 2017: Multiple Myeloma Overview with Dr. Saad Usmani

In this video, Dr. Saad Usmani from the Levine Cancer Institute discusses the multiple myeloma clinical trials and abstracts presented at this past weekend’s annual American Society of Clinical Oncologists (ASCO) meeting. View more topline videos from ASCO 2017.

 

Spring Edition of Myeloma Today: Promising Clinical Trials in 2017...and More

The latest issue of Myeloma Today is out with news about the latest Black Swan Research Initiative® projects as well as the most promising clinical trials in 2017. Also in this issue, the InfoLine addresses drug access issues in a time of transition. For a dose of inspiration, check out highlights from Myeloma ACTION Month. Download the Spring edition of Myeloma Today now.

 

Watch a Replay of the "Living Well with Myeloma" Webinar on Nutrition

Watch a replay of last week’s “Living Well with Myeloma” webinar on Nutrition. Hosted by Kylie Buchan of Savor Health, the talk covers the importance of nutrition, management of treatment-related side effects, food safety, multiple myeloma complications, and survivorship.

Global Myeloma Action Network (GMAN) Funding Helps Launch Three Innovative Projects

The 2017 Susie Novis Durie Grants provide funding for GMAN member organizations to implement programs aligned with the coalition's mission to improve the lives of myeloma patients around the world by raising the profile and enhancing the capabilities of patient advocacy groups, increasing myeloma awareness, and improving patients' access to myeloma treatments. Learn about the important projects of this year's grant recipients from Argentina, Austria, and Romania HERE.

Bake Sales, Barbecues, and Wine Tastings: Oh My! Plan Your Summer FUNdraising Activity Now

Did you know that the IMF has staff members who can work with you to organize events? In the spirit of summer, brainstorm with Suzanne Battaglia, the IMF’s Director of Member Events, about simple and stress-free ways to raise myeloma awareness. Bake Sale? Picnic? Garage Sale? Wine & Cheese Party? 4th of July party? Backyard BBQ? Anything you can think of to do, we are here ready to help you. Contact Suzanne today!

 

If I have a sustained remission and am on Revlimid, should I continue using it?

In this week’s video, In this week's video, Dr. Brian Durie answers a patient's concern about the potential of adverse side effects or toxicity issues from long-term Revlimid use.

 

 


We Would Like to Thank Our Sponsors: Takeda, Celgene, Amgen, and Bristol-Myers Squibb